Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Recruiting · NCT02604277 · Interventional (participants receive a specific treatment) · Lead sponsor: Emory University
View the official record on ClinicalTrials.gov →Interventions studied
Bipolar-Specific Cognitive Behavioral Therapy (CBT)Interpersonal and Social Rhythm Therapy (ISRT)Mindfulness-Based Stress Reduction (MBSR)Psycho-education & Understanding Bipolar Medications Therapy
What this trial is about
The purpose of this study is to learn the environmental and psychological factors that impact suicidality in patients diagnosed with Bipolar Disorder. Additionally, the study aims to identify treatments to reduce the suicidal behavior and improve quality of life through a 6-week group-based intervention program.
Who can take part
Age range
18 Years to 64 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- English speaking
- Diagnosis of Bipolar Disorder (BD)
- Able to provide written informed consent
Exclusion criteria
- Cognitive impairments
- Acutely psychotic
- Medically unstable
- History of schizophrenia spectrum disorder
- History of mood incongruent psychotic symptoms
- History of primary substance disorder
- History of primary organic disease and/or dementia
Where it is running
1 location listed across 1 US state.
- Grady Health System - Atlanta, Georgia, United States